A detailed history of Td Private Client Wealth LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 9,756 shares of EXEL stock, worth $339,801. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,756
Previous 2,046 376.83%
Holding current value
$339,801
Previous $46 Million 450.68%
% of portfolio
0.01%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024

BUY
$21.96 - $27.6 $169,311 - $212,796
7,710 Added 376.83%
9,756 $253 Million
Q2 2024

Aug 14, 2024

BUY
$20.34 - $23.73 $41,615 - $48,551
2,046 New
2,046 $46 Million
Q1 2024

Aug 16, 2024

BUY
$20.17 - $23.93 $10,044 - $11,917
498 Added 25.91%
2,420 $57.4 Million
Q4 2022

Aug 16, 2024

SELL
$14.96 - $17.39 $3,201 - $3,721
-214 Reduced 10.02%
1,922 $30.8 Million
Q1 2022

Aug 16, 2024

BUY
$17.03 - $22.67 $36,376 - $48,423
2,136 New
2,136 $48.4 Million
Q4 2021

Aug 16, 2024

SELL
$15.84 - $21.88 $2,217 - $3,063
-140 Closed
0 $0
Q3 2021

Aug 16, 2024

SELL
$16.3 - $21.14 $31,067 - $40,292
-1,906 Reduced 93.16%
140 $2.96 Million
Q1 2021

Aug 16, 2024

SELL
$20.53 - $25.22 $328 - $403
-16 Reduced 10.26%
140 $3.16 Million
Q4 2019

Aug 16, 2024

SELL
$15.15 - $18.89 $28,633 - $35,702
-1,890 Reduced 92.38%
156 $2.75 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.2B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.